Skip to main content
    Health Library

    Weight management · 4 min read · Evidence-informed guide

    Stopping a GLP-1 Medicine: Questions to Ask First

    Do not stop, restart, or change the dose of a GLP-1 medicine without discussing it with the prescribing clinician. The reason for treatment, diabetes medicines, side effects, pregnancy plans, access, and the possibility of weight regain or glucose changes all affect a safe transition plan.

    Key answer

    The short version

    Do not stop, restart, or change the dose of a GLP-1 medicine without discussing it with the prescribing clinician. The reason for treatment, diabetes medicines, side effects, pregnancy plans, access, and the possibility of weight regain or glucose changes all affect a safe transition plan.

    Understand why the plan is changing

    Treatment may change because of side effects, cost, coverage, pregnancy, a procedure, a new diagnosis, or a shift in goals. The right response depends on the reason and the medicine being used.

    Avoid unsafe restart patterns

    After a break, restarting at a prior dose may not be appropriate. The prescriber can determine whether a different dose, schedule, medicine, or non-medication plan is needed.

    Plan for continuity of care

    Ask how nutrition, activity, sleep, monitoring, and follow-up will continue if a medicine is paused or stopped. If you also use diabetes medicine, ask how glucose management will be affected.

    Clinical perspective

    How to think about this

    Prescription weight management is longitudinal medical care, not a consumer transaction. A sound plan weighs approved use, safety, nutrition, access, follow-up, and the patient’s own goals; it should never reduce a complex health decision to a promised outcome or a single number on a scale.

    Questions worth bringing to a visit

    • What FDA-approved option, if any, fits my clinical situation?
    • What safety monitoring and follow-up would I need?
    • How will we assess benefit, tolerability, and access over time?

    Continue exploring

    Related patient questions

    GLP-1 Weight-Loss Medicines: Questions to AskRead article Semaglutide vs. Tirzepatide: What Is the Difference?Read article Who May Qualify for GLP-1 Weight-Loss Medicine?Read article

    Sources

    1. 1. FDA, Wegovy Prescribing Information

      Dose escalation, missed-dose, and safety guidance.

    2. 2. NIDDK, Prescription Medications to Treat Overweight & Obesity

      Medication as part of long-term weight-management care.